Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    • News

  • Wildcat delivers Australia’s largest undeveloped lithium resource
    • News

    Wildcat delivers Australia’s largest undeveloped lithium resource

    Mineral exploration business Wildcat Resources (ASX: WC8) has unveiled a significant resource estimate for its Tabba Tabba project in the Pilbara region of Western Australia, consisting of 74.1 million tonnes at a grade of 1.0 per cent lithium. According to the company, the project now holds Australia’s largest undeveloped publicly reported hard-rock lithium deposit. The

    Read More
    Public
  • AML3D raise to fund doubling of US capacity and other growth initiatives
    • News

    AML3D raise to fund doubling of US capacity and other growth initiatives

    AML3D (ASX:AL3) announced the successful completion of a two-tranche institutional placement (“Placement”) to sophisticated investors, raising approximately $30 million. The Placement will see around 157.9 million new fully paid ordinary shares in AML3D issued at a price of $0.19 per share. The Placement was strongly supported by both existing AML3D shareholders and new institutional investors

    Read More
    Public
  • Encounter Resources drill results confirm ‘high-grade’ niobium discovery
    • News

    Encounter Resources drill results confirm ‘high-grade’ niobium discovery

    Encounter Resources (ASX:ENR) rose after announcing that the first reverse circulation (RC) drilling results from its Green prospect at the Aileron project in the West Arunta region of WA hosts extensive, enriched, high-grade niobium mineralisation in the upper portion of the system. Of the four initial RC holes completed in Green’s western area, three returned

    Read More
    Public
  • Singular Health Group signs MOU and completes equity placement
    • News

    Singular Health Group signs MOU and completes equity placement

    Medical technology company Singular Health Group rose after it announced the signing of a Memorandum of Understanding (MOU) with Provider Network Solutions (PNS) to collaborate on a technical proof-of-concept and commercial pilot within the PNS Network. Singular Health also announced the completion of a successful equity placement of AUD3.7M at $0.09 per share, including an

    Read More
    Public
  • Resonance soars on $14m contract win with big pharma
    • News

    Resonance soars on $14m contract win with big pharma

    The share price of healthcare technology and services business Resonance Health (ASX: RHT) surged by more than 50 per cent on Tuesday after the company nailed down a two-year clinical trial agreement with Indian multinational pharmaceutical titan, Sun Pharmaceuticals. The $13.775 million deal will see Resonance act as the local Australian sponsor and provide clinical

    Read More
    Public
  • Petratherm surges on ‘outstanding’ Rosewood metallurgical results
    • News

    Petratherm surges on ‘outstanding’ Rosewood metallurgical results

    Petratherm (ASX:PTR) rallied strongly after announcing results from an initial trial heavy mineral sand (HMS) separation test using samples collected from historic drill holes stored at the South Australian Core Library (CAR series drill holes). The composite samples were collected from widely spaced contiguous drill holes along a 2.5-kilometre-long traverse on the eastern side of

    Read More
    Public
  • Spectur nails down long-term government contract as sales gather momentum
    • News

    Spectur nails down long-term government contract as sales gather momentum

    Spectur (ASX: SP3), a specialist in smart security systems powered by solar technology, has locked in a three-year agreement valued at close to $800,000 for the provision of its cameras and analytic services to government agency Transport for New South Wales. The contract also allows for a potential site expansion which could help boost the

    Read More
    Public
  • Aussie mining heads to paradise for showpiece industry event
    • News

    Aussie mining heads to paradise for showpiece industry event

    The Australian mining industry flocked to tropical Queensland this week for one of the most distinguished events on the calendar for ASX-listed producers, explorers, and resource developers: the Noosa Mining Investor Conference hosted by Brisbane-based outfit, Equity Events. Held twice a year at the Peppers Noosa Resort on the top end of Queensland’s pristine Sunshine

    Read More
    Public
  • Biome leaps into Canada as sales in Australia skyrocket
    • News

    Biome leaps into Canada as sales in Australia skyrocket

    Biome Australia (ASX: BIO), a healthcare business specialising in developing, marketing, and distributing probiotic and complementary health products, has spread its wings into the Canadian market after generating positive feedback and encouraging early sales during a two-month testing period. Management believes the Canadian market is now adequately derisked for the company to march forward with

    Read More
    Public
  • EMVision takes key step in advancing stroke diagnosis technology
    • News

    EMVision takes key step in advancing stroke diagnosis technology

    Medical device company EMVision (ASX: EMV) has reported “excellent” results from a study gauging the effectiveness of its cutting-edge neurodiagnostic technology for the identification of stroke and stroke types. The multi-site study – known as EMView – involved the testing of diagnostic algorithms on unseen data from 307 participants across the Liverpool, Royal Melbourne, and

    Read More
    Public
  • «
  • ‹
  • 14
  • 15
  • 16
  • 17
  • 18
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.